Open-label, phase II, multicenter trial of ZD1839 ('Iressa') in patients with advanced breast cancer
Published in 2002 by
K. Albain,
R. Elledge,
W. J. Gradishar,
D. F. Hayes,
E. Rowinsky,
C. Hudis,
L. Pusztai,
D. Tripathy,
S. Modi 
,
S. Rubi
,
S. Rubi
